Skip to main content
. 2020 Sep 24;9(39):e00783-20. doi: 10.1128/MRA.00783-20

TABLE 1.

Antibiotics tested and resistance genes identified in the K. pneumoniae isolate

Drug class Drug(s) tested Susceptibility test resulta Resistance gene(s)
Aminoglycosides NDb ND armA, aac(3)-IV, aac(6')-Ib-cr, aadA1, aadA16, aadA2, aph(3'')-Ib, aph(3')-Ia, aph(4)-Ia, aph(6)-Id
Monobactams Aztreonam S None identified
Carbapenems Meropenem S None identified
β-Lactams (cephalosporins) Ceftriaxone S blaDHA-1, blaSHV-28
Cefepime S
Cefuroxime R
Cefixime R
Penicillins Piperacillin R
Ampicillin-sulbactam R
Fluoroquinolones Levofloxacin R oqxA, oqxB, qnrB2, qnrB4
Moxifloxacin R
Tetracyclines Tetracycline I None identified
Tigecycline I
Minocycline S
Phenicols Chloramphenicol R cmlA1, floR
Rifampin ND ND ARR-3
Trimethoprim Trimethoprim R dfrA27
Fosfomycin ND ND fosA, mdf(A)
Macrolides ND ND mph(E), msrE
Sulfonamides ND ND sul1, sul3
Polymyxins Colistin S (I/R)c mcr-8
a

Resistance classifications are based on CLSI guidelines (16) and the Vitek 2 Advanced Expert System. S, susceptible; R, resistant; I, intermediate.

b

ND, not done.

c

The isolate tested intermediate on the Vitek 2 system and the Etest and resistant on the MicroScan system using the 2020 CLSI breakpoints (17).